Abingworth LLP - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 24 filers reported holding PROTEON THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Abingworth LLP ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$344,000
-60.9%
20,610
-99.0%
0.07%
-82.6%
Q4 2019$879,000
+67.4%
2,144,517
+6.3%
0.42%
+28.0%
Q3 2019$525,000
-38.3%
2,017,8720.0%0.33%
+1.8%
Q2 2019$851,000
-15.7%
2,017,8720.0%0.33%
-63.9%
Q1 2019$1,009,000
-78.0%
2,017,8720.0%0.90%
-78.3%
Q4 2018$4,581,000
+19.5%
2,017,8720.0%4.16%
+82.6%
Q3 2018$3,834,000
-20.8%
2,017,8720.0%2.28%
-17.6%
Q2 2018$4,843,000
-4.0%
2,017,8720.0%2.77%
-11.8%
Q1 2018$5,045,000
+35.1%
2,017,8720.0%3.14%
+15.9%
Q4 2017$3,733,000
-5.1%
2,017,8720.0%2.70%
-0.7%
Q3 2017$3,935,000
+30.0%
2,017,8720.0%2.72%
+13.1%
Q2 2017$3,027,000
-11.7%
2,017,8720.0%2.41%
-5.8%
Q1 2017$3,430,000
-5.6%
2,017,8720.0%2.56%
-15.8%
Q4 2016$3,632,000
-80.2%
2,017,8720.0%3.04%
-82.8%
Q3 2016$18,383,000
+13.0%
2,017,8720.0%17.62%
+3.5%
Q2 2016$16,264,000
+4.5%
2,017,8720.0%17.03%
+17.8%
Q1 2016$15,558,000
-50.3%
2,017,8720.0%14.46%
-23.4%
Q4 2015$31,277,000
+14.1%
2,017,8720.0%18.88%
+17.8%
Q3 2015$27,423,000
-23.9%
2,017,8720.0%16.02%
-2.1%
Q2 2015$36,039,000
+59.0%
2,017,8720.0%16.36%
+69.7%
Q1 2015$22,661,000
+11.4%
2,017,8720.0%9.64%
+66.8%
Q4 2014$20,340,0002,017,8725.78%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$15,558,00014.46%
MPM ASSET MANAGEMENT LLC 983,381$7,611,0002.36%
RA Capital Management 1,626,931$12,592,0001.61%
Omega Fund Management, LLC 250,000$1,935,0001.34%
Deer VII & Co. Ltd. 315,101$2,439,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$9,794,0000.42%
Monashee Investment Management LLC 14,615$113,0000.21%
Perceptive Advisors 275,000$2,129,0000.19%
TIVERTON ASSET MANAGEMENT LLC 264,778$2,049,0000.07%
Baker Brothers Advisors 298,591$2,311,0000.02%
View complete list of PROTEON THERAPEUTICS INC shareholders